FOLD

FOLD

USD

Amicus Therapeutics Inc. Common Stock

$8.990-0.010 (-0.111%)

Precio en Tiempo Real

Healthcare
Biotecnología
Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$9.000

Máximo

$9.640

Mínimo

$8.860

Volumen

6.71M

Fundamentos de la Empresa

Capitalización de Mercado

2.8B

Industria

Biotecnología

País

United States

Estadísticas de Negociación

Volumen Promedio

4.74M

Bolsa

NGM

Moneda

USD

Rango de 52 Semanas

Mínimo $5.51Actual $8.990Máximo $12.65

Noticias Relacionadas

GlobeNewswire

Amicus Therapeutics Announces Third Quarter 2025 Financial Results and Corporate Updates

Q3 2025 Total Revenue of $169M, up 17% at CER Positive Q3 2025 GAAP Net Income of $17M Cash Position of $264M, a $33M Increase in Q3 2025 Conference Call and Webcast Today at 8:30 a.m. ET PRINCETON, N.J., Nov. 04,

Ver más
Amicus Therapeutics Announces Third Quarter 2025  Financial Results and Corporate Updates
GlobeNewswire

Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2025

PRINCETON, N.J., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (NASDAQ:FOLD) today announced that management will participate in upcoming presentations at the following investor conferences in November. 2025

Ver más
Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2025